Pediatric Treatment Regimen for Malaria
Artemisinin-Based Combination Therapy (ACT) is First-Line
For uncomplicated Plasmodium falciparum malaria in children, artemether-lumefantrine (AL) dispersible formulation is the preferred first-line treatment, dosed according to weight-based bands and given twice daily for 3 days. 1, 2, 3
Weight-Based Dosing for Artemether-Lumefantrine
The standard pediatric regimen uses the following weight bands, with doses administered at 0,8,24,36,48, and 60 hours 1:
- 5 to <15 kg: 1 tablet per dose
- 15 to <25 kg: 2 tablets per dose
- 25 to <35 kg: 3 tablets per dose
- ≥35 kg: 4 tablets per dose (adult dosing)
Important safety note: AL dispersible should not be used in infants weighing <5 kg due to 2-3 fold higher artemether and dihydroartemisinin exposures that exceed preclinical safety margins for neurotoxicity. 4
Alternative ACT Options
When artemether-lumefantrine is unavailable or contraindicated, other effective ACTs include 1, 2, 5:
Dihydroartemisinin-piperaquine (DHA-PPQ): Demonstrates the highest PCR-corrected cure rate at 99.6% at both day 28 and day 42, with minimal heterogeneity across studies and the lowest adverse event rate (1.8%). 5
Atovaquone-proguanil (Malarone): Weight-based dosing for 3 days 1:
- 5-8 kg: 2 pediatric tablets (25 mg) daily
- 9-10 kg: 3 pediatric tablets daily
- 11-20 kg: 1 adult tablet (100 mg) daily
- 21-30 kg: 2 adult tablets daily
- 31-40 kg: 3 adult tablets daily
Mefloquine: 15 mg base/kg followed by 10 mg/kg at 8-24 hours later. 1
Chloroquine for Chloroquine-Sensitive Areas
In the rare settings where chloroquine resistance has not been documented, chloroquine remains an acceptable option with a total dose of 25 mg/kg over 3 days. 6, 2
Pediatric Chloroquine Dosing Schedule
- Day 0 (hour 0): 10 mg/kg
- Day 1 (hour 24): 10 mg/kg
- Day 2 (hour 48): 5 mg/kg
Total cumulative dose: 25 mg/kg 6, 2
Critical Caveat on Chloroquine Resistance
If the child remains symptomatic 48-72 hours after initiating chloroquine, obtain a repeat blood smear; persistent parasitemia indicates chloroquine resistance and mandates immediate switch to an ACT. 6, 2 Most regions now have widespread chloroquine resistance, making ACTs the de facto standard. 2, 7
Severe Malaria Requires Parenteral Therapy
For severe or complicated malaria (impaired consciousness, seizures, respiratory distress, severe anemia, hypoglycemia), intravenous artesunate is the treatment of choice. 1, 7
Parenteral Quinine Dosing (When Artesunate Unavailable)
- Loading dose: 20 mg salt/kg IV over 4 hours
- Maintenance: 10 mg/kg IV over 4 hours every 8 hours 1
Omit the loading dose if the child received mefloquine prophylaxis in the prior 24 hours or treatment dose within 3 days. 1
Switch to oral ACT as soon as the child can tolerate oral medications to complete a full treatment course. 1
Management of Common Complications
Seizure Management
Seizures occur in up to 25% of severe pediatric malaria cases and require immediate airway management with high-flow oxygen before anticonvulsants. 1
- First-line: Lorazepam 0.1 mg/kg IV/IO, may repeat once after 10 minutes 1
- Second-line: Paraldehyde 0.4 mg/kg rectally (0.8 mL/kg of prepared solution) 1
- Third-line: Phenytoin 18 mg/kg IV over 20 minutes OR phenobarbital 15-20 mg/kg IV over 10 minutes 1
Do not use prophylactic phenobarbital; a trial in Kenyan children showed increased mortality, particularly when combined with diazepam in unventilated settings. 1
Hypoglycemia Monitoring
Check blood glucose immediately in any child with seizures or altered consciousness, as hypoglycemia commonly precipitates neurological symptoms in severe malaria. 1
Plasmodium vivax Requires Radical Cure
For P. vivax infections, add primaquine 0.3 mg/kg/day for 14 days after completing blood-stage therapy to eradicate hypnozoites and prevent relapse. 2
Mandatory G6PD testing before primaquine: 2
- Normal activity (≥70%): Standard 14-day course
- Intermediate deficiency (30-70%): Weekly primaquine 0.75 mg/kg for 8 weeks with monitoring
- **Severe deficiency (<30%) or Asian populations without testing:** Do NOT give primaquine for >5 days due to life-threatening hemolysis risk 6, 2
Key Clinical Pitfalls
Never assume fever equals malaria alone—always consider pneumonia, acute lower respiratory infection, or meningitis as alternative or concurrent diagnoses, particularly in high-transmission areas. 6
Supervised first dose is critical: If 3-day supervised therapy is impossible, administer the first dose under direct observation and provide remaining doses with clear instructions. 6
Food intake with artemether-lumefantrine: Although efficacy data show high cure rates regardless of food intake, absorption is enhanced with fatty meals; counsel caregivers accordingly. 3